Home
About
FAQ
History (7)
LOH at 16p13 is a novel chromosomal alteration detected in benign and malignant microdissected papillary neoplasms of the breast.
On and off the horse: mechanisms and patterns of injury in mounted and unmounted equestrians.
The Role of the Clinical Pharmacist in a Preventive Cardiology Practice.
Antibiotics, Antitubercular
Small Interfering RNA Therapeutic Inclisiran: A New Approach to Targeting PCSK9.
See All 7 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Small Interfering RNA Therapeutic Inclisiran: A New Approach to Targeting PCSK9.
German CA, Shapiro MD. Small Interfering RNA Therapeutic Inclisiran: A New Approach to Targeting PCSK9. BioDrugs. 2020 Feb; 34(1):1-9.
View in:
PubMed
subject areas
Atherosclerosis
Cardiovascular Diseases
Humans
Hypercholesterolemia
RNA, Small Interfering
authors with profiles
Michael D. Shapiro DO, MCR